Navigation Links
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
Date:9/19/2013

London (PRWEB) September 19, 2013

Summary

GlobalData has released its pharma report, “PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing RSV Market. The report identifies and analyses the key companies shaping and driving the global RSV market. The report provides insight into the competitive RSV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Investigation of current and future market competition for RSV
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the RSV sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving the RSV Market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • What’s the next big thing in the global RSV market landscape? Identify, understand and capitalize.

Table of Contents

1 Table of Contents 7
1.1 List of Tables 9
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
3 Market Outlook 11
3.1 US 11
3.1.1 Forecast 11
3.1.2 Key Events 13
3.1.3 Drivers and Barriers – Global Issues 13
4 Current and Future Players 18
4.1 Overview 18
4.2 Trends in Corporate Strategy 19
4.3 Company Profiles 21
4.3.1 AstraZeneca (MedImmune) 21
4.3.2 Novavax 23
5 Appendix 26
5.1 Bibliography 26
5.2 Abbreviations 27
5.3 Methodology 28
5.4 Forecasting Methodology 28
5.4.1 Number of eligible patients for prophylaxis 28
5.4.2 Utilization rates of Synagis 29
5.4.3 Patient share and generic erosion 30
5.4.4 Weight of high risk infants 30
5.4.5 Cost per day 30
5.4.6 Number of prophylaxis days per year 30
5.4.7 Annual cost of therapy 31
5.4.8 Patient compliance 31
5.4.9 Total sales 31
5.4.10 Drugs Included in Each Therapeutic Class 31
5.4.11 Launch and Patent Expiry Dates 31
5.4.12 General Pricing Assumptions 32
5.4.13 Individual Drug Assumptions 32
5.5 Physicians and Specialists Included in this Study 33
5.6 About the Authors 34
5.6.1 Authors 34
5.6.2 Epidemiologist 35
5.6.3 Global Head of Healthcare 35
5.7 About GlobalData 36
5.8 Contact Us 36
5.9 Disclaimer 36

List of Tables

Table 1: US Sales Forecasts ($m) for Synagis, 2012–2022 12
Table 2: Key Events Impacting Sales for RSV Prophylactics in the US, 2012 13
Table 3: Pediatric RSV Market – Drivers and Barriers, 2012 13
Table 4: Key Companies in the Pediatric RSV Prophylactic Market – United States, 2012 18
Table 5: AstraZeneca’s RSV Prophylactics Portfolio Assessment, 2013 22
Table 6: AstraZeneca SWOT Analysis, 2012 22
Table 7: Novavax’s Pediatric RSV Prophylactics Portfolio Assessment, 2012 24
Table 8: Novavax SWOT Analysis, 2012 25
Table 9: Key Launch Date 31
Table 10: Key Patent Expiries 31

List of Figures

Figure 1: Company Portfolio Gap Analysis in Pediatric RSV, 2012–2022 18

Companies Mentioned

  • AstraZeneca (MedImmune)
  • Novavax

Read the full report:

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players

http://www.reportbuyer.com/pharma_healthcare/diseases/pharmapoint_pediatric_respiratory_syncytial_virus_rsv_prophylactics_current_future_players.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reporbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11140577.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
3. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
4. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
5. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
6. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
7. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
8. Many Parents of Kids With Autism Dont Put Faith in Pediatricians
9. Pediatric epilepsy impacts sleep for the child and parents
10. Tiny Tots in the Dentists Chair Among Changes in Pediatric Dentistry
11. Pediatric kidney expert receives Young Investigator Award from American Transplant Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of its new medical office in Petaluma, located at 167 Lynch Creek Way. ... access to SRO sports medicine and rehabilitation services and on-site x-ray ...
(Date:1/20/2017)... ... 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built ... is mounted on wheels, it can be wheeled out of the way and stored when ... the deck. "We have transformed the feedback from customers into specific enhancements and created a ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company ... with school-aged children since the holiday season. , “It happens every year around ... sharing hugs and taking photos, which is the head-to-head gateway that lice need to ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , January 20, 2017 Avillion LLP, ... appointment of Mark Weinberg , MD MBA as Chief Medical ... , USA . ... Dr Weinberg has spent more than 17 years ... 20" pharma companies to micro-cap biotech. Over the course of his ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 Report ... Ophthalmic Devices Market? Which areas are going to grow ... potential revenues to 2026, assessing data, trends, opportunities and ... and graphs. Discover the most lucrative areas in the ... lets you assess forecasted sales across the all the ...
(Date:1/19/2017)... 2017 Conference Call and Webcast to Follow ... it will release results for the fourth quarter of 2016 on ... ... call at 4:30 PM ET on Wednesday, February 15, 2017, during ... financial results and other corporate activities. To participate in the conference ...
Breaking Medicine Technology: